A meta-analysis was conducted of 125 studies on psychotherapy dropout. Mean dropout rate was 46.86%. Dropout rate was unrelated to most of the variables that were examined but differed significantly as a function of definition of dropout. Lower dropout rates occurred when dropout was defined by termination because of failure to attend a scheduled session than by either therapist judgment or number of sessions attended. Significant effect sizes were observed for 3 client demographic variables: racial status, education, and income. Dropout rates increased for African-American (and other minority), less-educated, and lower income groups. Recommendations for future psychotherapy dropout research are presented.
A parent form of the Children's Depression Inventory (CDI) was investigated in a nonclinical population. In Study 1, the CDI was administered to 50 children and their mothers. One month later, the CDI was readministered to 45 children and their mothers. Children's and mothers' CDI ratings were correlated significantly at both Time 1 (r = .37) and Time 2 (r = .59). Test‐retest reliability of the Parent‐CDI over the 1‐month interval was significant (r = .75). In Study 2, 96 children were rated by mothers on the CDI. Eighty‐one of these children rated themselves on the CDI, and 72 were rated by teachers on the Children's Depression Rating Scale (CDRS). The Parent‐CDI was found to be correlated significantly with both the CDI (r = .66) and the CDRS (r = .64). Internal consistency of the Parent‐CDI was demonstrated by both a split‐half and an item‐total analysis. Merits and limitations of this parent form of the CDI for use within a nonclinical population are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.